The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…
Read More
US Food and Drug Administration Unveils Draft Guidance for Genome Editing Therapies, Prioritizing Safety Through Next-Generation Sequencing
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read MoreYOU MAY HAVE MISSED
